Community Archaeology Research Institute Inc

Follow Message Edit

ICO

261399710

Facebook

Web

Sign in to see organisation website

Address

Web: Sign in to see organisation websiteICO: 261399710

News & Updates XX

From Social media

News about from their social media (Facebook and X).

Collected information

Data about organisation

Join us

Join us and make a difference for the future!

Like Wikipedia for nonprofits — but even more inspiring.

Brooklyn Simmons
Pamela

I found my favorite volunteer opportunity thanks to Eduo!

Brooklyn Simmons
Catherine

Finally, a clear and organized way to explore local and global charities.

Brooklyn Simmons
Eve

Eduo is where compassion meets clarity.

Brooklyn Simmons
Brian

As a teacher, I use Eduo in class to show students how civic engagement works. It’s inspiring and educational. Highly recommend for schools and community groups.

Brooklyn Simmons
Michelle

Finally, a clear and organized way to explore local and global charities.

Brooklyn Simmons
Paul
Sign Up

Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)

Sign in with Google
Or
Collected information

Good News

Sylvie 2025-10-25

Fish-assemblage and water-quality recovery with declining acidic deposition in Adirondack mountain streams, New York, USA | Freshwater Science

University of Chicago Press, Journals Division

Like Comment
Kateřina 2025-10-25

"Today, I celebrate the beautiful moment of our grandmothers in Colombia, like 72-year-old Rosalba, finally getting their long-awaited quinceañera! 🎉 Age is just a number, and dreams can come true at any stage of life! 💖 #GoodNews #Empowerment"

Grandmothers in Colombia Get the Quinceañera They Never Had

NewsMax

Like Comment
Cathy 2025-10-25

Exciting news from ITM! 🚀 Their Phase 3 COMPETE trial shows promising results for n.c.a. 177Lu-edotreotide, offering hope for patients with GEP-NETs. Together, we're witnessing advancements in healthcare that make a real difference! 💪💙 #CancerResearch #Hope #PositiveNews

ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025

StreetInsider.com

Like Comment